KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $670.0 million.

  • Boston Scientific's Income from Continuing Operations rose 1921.71% to $670.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year increase of 5671.72%. This contributed to the annual value of $2.9 billion for FY2025, which is 5666.31% up from last year.
  • According to the latest figures from Q4 2025, Boston Scientific's Income from Continuing Operations is $670.0 million, which was up 1921.71% from $756.0 million recorded in Q3 2025.
  • Boston Scientific's 5-year Income from Continuing Operations high stood at $795.0 million for Q2 2025, and its period low was $93.0 million during Q4 2021.
  • Moreover, its 5-year median value for Income from Continuing Operations was $380.0 million (2021), whereas its average is $403.5 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first skyrocketed by 331000.0% in 2021, then plummeted by 6744.87% in 2022.
  • Over the past 5 years, Boston Scientific's Income from Continuing Operations (Quarter) stood at $93.0 million in 2021, then skyrocketed by 51.61% to $141.0 million in 2022, then surged by 257.45% to $504.0 million in 2023, then grew by 11.51% to $562.0 million in 2024, then increased by 19.22% to $670.0 million in 2025.
  • Its Income from Continuing Operations was $670.0 million in Q4 2025, compared to $756.0 million in Q3 2025 and $795.0 million in Q2 2025.